FR2670783B1 - Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant. - Google Patents

Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.

Info

Publication number
FR2670783B1
FR2670783B1 FR919112515A FR9112515A FR2670783B1 FR 2670783 B1 FR2670783 B1 FR 2670783B1 FR 919112515 A FR919112515 A FR 919112515A FR 9112515 A FR9112515 A FR 9112515A FR 2670783 B1 FR2670783 B1 FR 2670783B1
Authority
FR
France
Prior art keywords
terbutylphenyl
hydroxybutane
amino
processes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR919112515A
Other languages
English (en)
Other versions
FR2670783A1 (fr
Inventor
Paule Bonnet
Remi Delansorne
Maurice Faure
Michel Lanquetin
Serge Zunino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Publication of FR2670783A1 publication Critical patent/FR2670783A1/fr
Application granted granted Critical
Publication of FR2670783B1 publication Critical patent/FR2670783B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR919112515A 1990-10-17 1991-10-11 Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant. Expired - Fee Related FR2670783B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909012562A FR2668150B1 (fr) 1990-10-17 1990-10-17 Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.

Publications (2)

Publication Number Publication Date
FR2670783A1 FR2670783A1 (fr) 1992-06-26
FR2670783B1 true FR2670783B1 (fr) 1994-11-18

Family

ID=9401134

Family Applications (2)

Application Number Title Priority Date Filing Date
FR909012562A Expired - Fee Related FR2668150B1 (fr) 1990-10-17 1990-10-17 Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
FR919112515A Expired - Fee Related FR2670783B1 (fr) 1990-10-17 1991-10-11 Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR909012562A Expired - Fee Related FR2668150B1 (fr) 1990-10-17 1990-10-17 Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.

Country Status (23)

Country Link
US (1) US5461059A (fr)
EP (1) EP0505543A1 (fr)
JP (1) JPH05503298A (fr)
KR (1) KR927003589A (fr)
AP (1) AP282A (fr)
BG (1) BG60680B1 (fr)
BR (1) BR9106188A (fr)
CA (1) CA2071911A1 (fr)
CZ (1) CZ182292A3 (fr)
FI (1) FI922773A0 (fr)
FR (2) FR2668150B1 (fr)
HU (1) HUT61297A (fr)
IE (1) IE913636A1 (fr)
IL (1) IL99776A0 (fr)
MA (1) MA22321A1 (fr)
NO (1) NO922358L (fr)
NZ (1) NZ240274A (fr)
OA (1) OA09835A (fr)
PL (2) PL169452B1 (fr)
PT (1) PT99266A (fr)
RO (1) RO108241B1 (fr)
WO (1) WO1992006977A1 (fr)
ZA (1) ZA918282B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
CA2161876A1 (fr) * 1993-05-20 1994-12-08 Den-Ichi Momose Composes de type 1-(2-benzimidazolyl)-1,5-diazacyclooctane
ES2072193B1 (es) * 1993-05-21 1996-02-16 Espanola Prod Quimicos Nuevos derivados del1-fenilmetil bencimidazol piperacinas.
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
EP0904080A4 (fr) * 1996-04-03 2001-08-01 Merck & Co Inc Inhibiteurs de farnesyle-proteine transferase
AU2001268958B2 (en) * 2000-07-04 2006-03-09 Novo Nordisk A/S Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
WO2004009091A1 (fr) * 2002-06-17 2004-01-29 Glaxo Group Limited Agonistes des recepteurs x du foie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130095C (fr) * 1962-08-31
US3161645A (en) * 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3491103A (en) * 1963-12-19 1970-01-20 Sandoz Ag Certain 4h-benzo(4,5)cyclohepta-(1,2-b) thiophenes
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
WO1989010363A1 (fr) * 1988-04-28 1989-11-02 Schering Corporation Composes polycycliques fusionnes, compositions, procedes de fabrication et leurs utilisations comme antagonistes du paf, antihistamines et/ou agents anti-inflammatoires
US4908372A (en) * 1988-10-13 1990-03-13 Merrell Dow Pharmaceuticals Inc. Antihistaminic piperidinyl benzimidazoles
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
US5217980A (en) * 1990-07-19 1993-06-08 Janssen Pharmaceutica N.V. Oxazolyl and piperidinyl substituted benimidazolyl compounds

Also Published As

Publication number Publication date
FR2670783A1 (fr) 1992-06-26
BR9106188A (pt) 1993-03-16
KR927003589A (ko) 1992-12-18
JPH05503298A (ja) 1993-06-03
WO1992006977A1 (fr) 1992-04-30
AP9100328A0 (en) 1991-10-31
FI922773A (fi) 1992-06-16
NO922358D0 (no) 1992-06-16
HUT61297A (en) 1992-12-28
BG60680B1 (bg) 1995-12-29
RO108241B1 (ro) 1994-03-31
FR2668150A1 (fr) 1992-04-24
PL169022B1 (pl) 1996-05-31
US5461059A (en) 1995-10-24
CZ182292A3 (en) 1993-01-13
PL169452B1 (pl) 1996-07-31
NO922358L (no) 1992-08-11
IE913636A1 (en) 1992-04-22
AP282A (en) 1993-09-08
FR2668150B1 (fr) 1994-11-18
FI922773A0 (fi) 1992-06-16
HU9202176D0 (en) 1992-10-28
MA22321A1 (fr) 1992-07-01
IL99776A0 (en) 1992-08-18
ZA918282B (en) 1992-07-29
PT99266A (pt) 1992-08-31
OA09835A (fr) 1994-08-15
NZ240274A (en) 1995-07-26
EP0505543A1 (fr) 1992-09-30
CA2071911A1 (fr) 1992-04-18

Similar Documents

Publication Publication Date Title
FR2569404B1 (fr) Nouveaux derives de 1,2-benzisothiazol-3-ylpiperazine, compositions pharmaceutiques contenant de tels composes et leurs procedes de preparation
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2676446B1 (fr) Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2665159B1 (fr) Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FR2664592B1 (fr) Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2569689B1 (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
FR2676056B1 (fr) Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
BE894805A (fr) Nouveaux derives du 3-amino pregn-5-ene, leurs sels, leur preparation, leur application a titre de medicaments et les compositions les renfermant
KR950700310A (ko) 헤테로트리사이클릭 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물(heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them)
FR2549832B1 (fr) Nouveaux derives de coumarine, leurs procedes de preparation, compositions pharmaceutiques les contenant
OA06651A (fr) Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation, les compositions pharmaceutiques les renfermant.
FR2753449B1 (fr) Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
FR2451910B1 (fr) Nouveaux derives amino-alcools, leurs procedes de preparation, et compositions pharmaceutiques renfermant ces produits
FR2653119B1 (fr) Nouveaux aryloxy alcoyl benzenes, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
FR2687678B1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2668150B1 (fr) Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
OA09137A (fr) Nouveaux dérivés de la benzoxazolinone, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
PT83593A (fr) Procede de preparation de 7-acyl-benzoxazinones et leurs derives et de compositions pharmaceutiques les contenant
FR2689509B1 (fr) Nouveaux derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
OA09439A (fr) "Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent".
FR2691459B1 (fr) Nouveaux derives de la phenothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
BE895924A (fr) Nouveaux derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les refermant
FR2539126B1 (fr) Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant
FR2669633B1 (fr) Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Legal Events

Date Code Title Description
ST Notification of lapse